- Home
- CHEB vs ME Comparison
CHEB vs ME Comparison
Compare CHEB & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEB
- ME
- Stock Information
- Founded
- CHEB 2024
- ME 2006
- Country
- CHEB Singapore
- ME United States
- Employees
- CHEB N/A
- ME N/A
- Industry
- CHEB
- ME Precision Instruments
- Sector
- CHEB
- ME Health Care
- Exchange
- CHEB NYSE
- ME Nasdaq
- Market Cap
- CHEB 118.7M
- ME 113.9M
- IPO Year
- CHEB 2024
- ME N/A
- Fundamental
- Price
- CHEB $10.06
- ME $3.24
- Analyst Decision
- CHEB
- ME Hold
- Analyst Count
- CHEB 0
- ME 1
- Target Price
- CHEB N/A
- ME $9.40
- AVG Volume (30 Days)
- CHEB 87.4K
- ME 393.2K
- Earning Date
- CHEB 01-01-0001
- ME 02-05-2025
- Dividend Yield
- CHEB N/A
- ME N/A
- EPS Growth
- CHEB N/A
- ME N/A
- EPS
- CHEB N/A
- ME N/A
- Revenue
- CHEB N/A
- ME $193,260,000.00
- Revenue This Year
- CHEB N/A
- ME $21.93
- Revenue Next Year
- CHEB N/A
- ME $17.31
- P/E Ratio
- CHEB N/A
- ME N/A
- Revenue Growth
- CHEB N/A
- ME N/A
- 52 Week Low
- CHEB $9.97
- ME $2.66
- 52 Week High
- CHEB $26.25
- ME $19.38
- Technical
- Relative Strength Index (RSI)
- CHEB N/A
- ME 38.88
- Support Level
- CHEB N/A
- ME $3.26
- Resistance Level
- CHEB N/A
- ME $3.50
- Average True Range (ATR)
- CHEB 0.00
- ME 0.35
- MACD
- CHEB 0.00
- ME 0.04
- Stochastic Oscillator
- CHEB 0.00
- ME 12.26
About CHEB CHENGHE ACQUISITION II CO
Chenghe Acquisition II Co is a blank check company.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.